CNBC June 13, 2019
- Dexcom CEO Kevin Sayer says its G6 upgrade for the Apple Watch will be a “great for people with diabetes.”
- A separate collaboration with Alphabet-subsidiary Verily will also be a device “for the ages,” he says.
- The medical device company wants to expand its relationships with Walgreens and CVS to “get the product to the patient where they can use it,′ he says.
Dexcom will launch a number of upgrades for its G6 diabetes system over the next year, including its direct-to-Apple Watch version, CEO Kevin Sayer said Thursday.